Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Nuclear Medicine Equipment Market expected to grow between 2026 and 2030?

The nuclear medicine equipment market size has demonstrated strong growth in recent years. It is forecast to grow from $2.81 billion in 2025 to $2.97 billion in 2026, at a compound annual growth rate (CAGR) of 5.7%. This historic growth can be ascribed to an aging population, increasing cancer prevalence, greater adoption of diagnostic imaging, expanding hospital infrastructure, and government funding for nuclear medicine.

The nuclear medicine equipment market is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach a value of $3.67 billion, exhibiting a compound annual growth rate (CAGR) of 5.4%. Factors contributing to this growth during the projected timeframe include the increased acceptance of theranostics, a rising demand for precision medicine, innovations in hybrid imaging technology, the escalating prevalence of cardiovascular diseases, and the establishment of more imaging centers in developing regions. Key trends anticipated for this period encompass sophisticated hybrid imaging systems, the broader application of theranostics, a greater uptake of individualized nuclear diagnostics, an intensified emphasis on optimizing radiation dosages, and a heightened need for outpatient nuclear imaging procedures.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20582&type=smp

Which Drivers Are Influencing Market Acceleration In The Nuclear Medicine Equipment Market?

The growing incidence of heart conditions is projected to boost the expansion of the nuclear medicine equipment market. These conditions, also identified as heart or cardiovascular diseases, encompass a wide array of illnesses impacting the heart and its associated blood vessels. Such ailments can detrimentally affect heart functionality, its anatomical structure, or the circulation of blood within the heart. The widespread occurrence of cardiac issues is largely linked to an aging global demographic, specific lifestyle decisions including inadequate nutrition and sedentary habits, exposure to environmental factors, and improvements in diagnostic tools that facilitate earlier discovery. In managing cardiac ailments, nuclear medicine equipment plays a crucial role by offering accurate imaging and diagnostic insights, which are vital for the early identification, precise classification, and effective observation of these conditions. For example, data released in January 2024 by the British Heart Foundation, a cardiovascular research charity based in the UK, revealed that approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases. This includes roughly 4 million males and 3.6 million females. These illnesses account for about 27% of all fatalities in the UK, amounting to more than 170,000 deaths per year, or approximately 480 deaths daily, which signifies one death every three minutes. Consequently, the rising occurrence of cardiac ailments is a key driver for the expansion of the nuclear medicine equipment market.

What Leading Segments Are Studied In The Nuclear Medicine Equipment Market?

The nuclear medicine equipment market covered in this report is segmented –

1) By Product: Single Photon Emission Computed Tomography, Hybrid Positron Emission Tomography, Planar Scintigraphy

2) By Application: Oncology, Cardiology, Neurology, Other Applications

3) By End User: Hospitals, Imaging Centers, Academic And Research Institutes, Other End Users

Subsegments:

1) By Single Photon Emission Computed Tomography: Standalone SPECT Systems, Hybrid SPECT Or CT Systems

2) By Hybrid Positron Emission Tomography: PET Or CT Systems, PET Or MRI Systems

3) By Planar Scintigraphy: Cardiac Imaging Systems, Bone Scintigraphy Systems, Thyroid Imaging Systems

What Industry Trends Are Transforming The Nuclear Medicine Equipment Market?

Leading companies within the nuclear medicine equipment market are prioritizing the development of sophisticated products, such as PET/CT scanners, to generate highly detailed, functional images of the body’s metabolic activities. A PET/CT scanner is an advanced medical imaging device employed in nuclear medicine, which integrates two technologies: positron emission tomography (PET) and computed tomography (CT). This innovative dual-modality scanner delivers both functional and anatomical imaging in a single session, empowering doctors to identify and diagnose various conditions with greater accuracy. For instance, in June 2024, Siemens Healthineers, a Germany-based healthcare enterprise, introduced the Biograph Trinion PET/CT scanner. This PET scanner is characterized by a distinctive, scalable axial field-of-view design, enabling technological upgrades directly on-site without requiring costly room modifications or interrupting workflow. It is equipped with a lutetium oxyorthosilicate (LSO) crystal detector, which provides high spatial resolution and an ultrafast time-of-flight performance of 239 picoseconds, thereby improving the detection of small lesions and ensuring sufficient sensitivity up to 128 cps/kBq. This technology facilitates rapid scans with reduced patient radiation exposure. Moreover, the Biograph Trinion features a novel air-cooled digital detector, simplifying its installation compared to conventional water-cooled systems.

Which Leading Companies Dominate The Nuclear Medicine Equipment Market Share?

Major companies operating in the nuclear medicine equipment market are Fujifilm Holdings Corporation, Koninklijke Philips N.V., General Electric Company, Shimadzu Corporation, Mallinckrodt Pharmaceuticals, Curium Pharma, Cardinal Health Inc., Canon Medical Systems Corporation, Digirad Corporation, TTG Imaging Solutions, Biodex Medical Systems Inc., Spectrum Dynamics Medical, Mediso Ltd., Cyclopharm Limited, Siemens Healthineers AG, Capintec Inc., Toshiba Medical Systems Corporation, Elysia-Raytest, DDD-Diagnostic A/S, MILabs B.V.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-equipment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Nuclear Medicine Equipment Market?

North America was the largest region in the nuclear medicine equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Nuclear Medicine Equipment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20582&type=smp

Browse Through More Reports Similar to the Global Nuclear Medicine Equipment Market 2026, By The Business Research Company

Nuclear Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Nuclear Decommissioning Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-decommissioning-services-global-market-report

Nuclear Fusion Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nuclear-fusion-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company